Padcev (enfortumab vedotin): Uses, How It Works, and Common Side Effects

Padcev is used to treat urothelial cancer, the most common type of bladder cancer, that is locally advanced or has spread. It is either used alone or in combination with pembrolizumab, also known as Keytruda. Learn more: https://www.drugs.com/padcev.html Padcev was first approved by the FDA in 2019. This medication is an antibody-drug conjugate. It contains an antibody that targets cancer cells, and microtubule-disrupting agent called MMAE. It works by attaching to cancer cells and releasing MMAE into these cells, which causes them to stop dividing and die. Padcev is given as an intravenous infusion by a healthcare provider on certain days during each chemotherapy cycle. Each infusion takes approximately 30 minutes. Common side effects of Padcev include high blood sugar, laboratory changes (such as liver and kidney tests), low blood cell counts, rash, fatigue, numbness or tingling in your hands or feet, hair loss, low appetite and weight loss, diarrhea or constipation, nausea, itching, dry eyes or skin, change in taste, and stomach pain. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult with your healthcare provider. References: 1. Drugs.com. Updated March 2025. Padcev Injection: Package Insert / Prescribing Info. Retrieved from https://www.drugs.com/pro/padcev-inje... 2. Padcev [package insert]. Updated Feb 2025. SEAGEN INC. Retrieved from: https://dailymed.nlm.nih.gov/dailymed... To learn more about any medication, or medical treatment, visit https://www.drugs.com —— Follow Drugs.com: Facebook:   / drugscom   X:   / drugscom   Instagram:   / drugs.com_official   TikTok:   / drugs.com_official   Pinterest:   / drugscom   Subscribe to our newsletter: https://www.drugs.com/newsletters/ —— About Drugs.com: Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.

Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles
▶︎

Enfortumab vedotin + Pembro FDA Approval in Muscle Invasive Bladder Cancer (MIBC): Dr. Thomas Powles

Cyclosporine, Mycophenolate Mnemonic for Nursing Pharmacology (NCLEX)
▶︎

Cyclosporine, Mycophenolate Mnemonic for Nursing Pharmacology (NCLEX)

How-to Overview: Repatha® SureClick® Autoinjector
▶︎

How-to Overview: Repatha® SureClick® Autoinjector

Drugs.com - Monthly Update November 2025
▶︎

Drugs.com - Monthly Update November 2025

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer
▶︎

Enfortumab vedotin plus pembrolizumab improves overall survival for advanced bladder cancer

Enfortumab vedotin + pembrolizumab in the first-line setting of a/mUC: the Italian clinical exper...
▶︎

Enfortumab vedotin + pembrolizumab in the first-line setting of a/mUC: the Italian clinical exper...

If you take a Statin, Do these 7 things Right Now! (Lipitor, Crestor, Zocor)
▶︎

If you take a Statin, Do these 7 things Right Now! (Lipitor, Crestor, Zocor)

Incredibly tasty spaghetti ready in 10 minutes! A quick, delicious pasta dinner recipe!
▶︎

Incredibly tasty spaghetti ready in 10 minutes! A quick, delicious pasta dinner recipe!

Padcev helping patients battling bladder cancer
▶︎

Padcev helping patients battling bladder cancer

My Immunotherapy Cancer Treatment Explained! (Keytruda) - Amanda | Rare Cancer | The Patient Story
▶︎

My Immunotherapy Cancer Treatment Explained! (Keytruda) - Amanda | Rare Cancer | The Patient Story

Locally advanced and metastatic urothelial carcinoma: the story has changed.
▶︎

Locally advanced and metastatic urothelial carcinoma: the story has changed.

Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM
▶︎

Enfortumab Vedotin–Pembrolizumab in Advanced Urothelial Cancer | NEJM

Ramipril vs. Candesartan – Das Ergebnis überrascht alle!
▶︎

Ramipril vs. Candesartan – Das Ergebnis überrascht alle!

Add THIS to Your Water After 60 to Activate Collagen, Eliminate Wrinkles, and Rejuvenate Your Skin
▶︎

Add THIS to Your Water After 60 to Activate Collagen, Eliminate Wrinkles, and Rejuvenate Your Skin

Double survival without chemotherapy in stage 4 - New cancer medicine Padcev 2025
▶︎

Double survival without chemotherapy in stage 4 - New cancer medicine Padcev 2025

Krebs-Killer - diese 10 Nährstoffe schützen wirklich!
▶︎

Krebs-Killer - diese 10 Nährstoffe schützen wirklich!

KEYNOTE-905: perioperative enfortumab vedotin and pembrolizumab in MIBC
▶︎

KEYNOTE-905: perioperative enfortumab vedotin and pembrolizumab in MIBC

Drugs.com - Monthly Update September 2025
▶︎

Drugs.com - Monthly Update September 2025

Tumore della Vescica Arriva la cura Enfortumab Vedotin
▶︎

Tumore della Vescica Arriva la cura Enfortumab Vedotin

What Is the New Enfortumab Vedotin + Pembrolizumab Treatment for Bladder Cancer?
▶︎

What Is the New Enfortumab Vedotin + Pembrolizumab Treatment for Bladder Cancer?